The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Effect of a Single High Dose of Vitamin D 3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial
Open accessAbstract
Importance: The efficacy of vitamin D3 supplementation in coronavirus disease 2019 (COVID-19) remains unclear. Objective: To investigate the effect of a single high dose of vitamin D3 on hospital length of stay in patients with COVID-19. Design, Setting, and Participants: This was a multicenter, double-blind, randomized, placebo-controlled trial conducted in 2 sites in Sao Paulo, Brazil. The study included 240 hospitalized patients with COVID-19 who were moderately to severely ill at the time of enrollment from June 2, 2020, to August 27, 2020. The final follow-up was on October 7, 2020. Interventions: Patients were randomly assigned to receive a single oral dose of 200 000 IU of vitamin D3 (n = 120) or placebo (n = 120). Main Outcomes and Measures: The primary outcome was length of stay, defined as the time from the date of randomization to hospital discharge. Prespecified secondary outcomes included mortality during hospitalization; the number of patients admitted to the intensive care unit; the number of patients who required mechanical ventilation and the duration of mechanical ventilation; and serum levels of 25-hydroxyvitamin D, total calcium, creatinine, and C-reactive protein. Results: Of 240 randomized patients, 237 were included in the primary analysis (mean [SD] age, 56.2 [14.4] years; 104 [43.9%] women; mean [SD] baseline 25-hydroxyvitamin D level, 20.9 [9.2] ng/mL). Median (interquartile range) length of stay was not significantly different between the vitamin D3 (7.0 [4.0-10.0] days) and placebo groups (7.0 [5.0-13.0] days) (log-rank P = .59; unadjusted hazard ratio for hospital discharge, 1.07 [95% CI, 0.82-1.39]; P = .62). The difference between the vitamin D3 group and the placebo group was not significant for in-hospital mortality (7.6% vs 5.1%; difference, 2.5% [95% CI, -4.1% to 9.2%]; P = .43), admission to the intensive care unit (16.0% vs 21.2%; difference, -5.2% [95% CI, -15.1% to 4.7%]; P = .30), or need for mechanical ventilation (7.6% vs 14.4%; difference, -6.8% [95% CI, -15.1% to 1.2%]; P = .09). Mean serum levels of 25-hydroxyvitamin D significantly increased after a single dose of vitamin D3 vs placebo (44.4 ng/mL vs 19.8 ng/mL; difference, 24.1 ng/mL [95% CI, 19.5-28.7]; P < .001). There were no adverse events, but an episode of vomiting was associated with the intervention. Conclusions and Relevance: Among hospitalized patients with COVID-19, a single high dose of vitamin D3, compared with placebo, did not significantly reduce hospital length of stay. The findings do not support the use of a high dose of vitamin D3 for treatment of moderate to severe COVID-19. Trial Registration: ClinicalTrials.gov Identifier: NCT04449718.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response
Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., Krutzik, S. R., Ochoa, M. T., Schauber, J., Wu, K., Meinken, C., et al. (2006) · Science · doi:10.1126/science.1123933 · Cited by 3,924
Martineau, A. R., Jolliffe, D. A., Hooper, R. L., Greenberg, L., Aloia, J. F., Bergman, P., Dubnov-Raz, G., Esposito, S., Ganmaa, D., Ginde, A. A., et al. (2017) · BMJ · doi:10.1136/bmj.i6583 · Cited by 2,040
Vitamin D status and ill health: a systematic review
Autier, P., Boniol, M., Pizot, C., & Mullie, P. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70165-7 · Cited by 1,107
Epidemic influenza and vitamin D
CANNELL, J. J., VIETH, R., UMHAU, J. C., HOLICK, M. F., GRANT, W. B., MADRONICH, S., GARLAND, C. F., & GIOVANNUCCI, E. (2006) · Epidemiology and Infection · doi:10.1017/s0950268806007175 · Cited by 1,034
Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts
Etten, E. V., & Mathieu, C. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.06.002 · Cited by 880
The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality
Ilie, P. C., Stefanescu, S., & Smith, L. (2020) · Aging Clinical and Experimental Research · doi:10.1007/s40520-020-01570-8 · Cited by 795
Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results
Meltzer, D. O., Best, T. J., Zhang, H., Vokes, T., Arora, V., & Solway, J. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.19722 · Cited by 510
Sabetta, J. R., DePetrillo, P., Cipriani, R. J., Smardin, J., Burns, L. A., & Landry, M. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011088 · Cited by 422
SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels
Kaufman, H. W., Niles, J. K., Kroll, M. H., Bi, C., & Holick, M. F. (2020) · PLOS ONE · doi:10.1371/journal.pone.0239252 · Cited by 384
MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19
Bilezikian, J. P., Bikle, D., Hewison, M., Lazaretti-Castro, M., Formenti, A. M., Gupta, A., Madhavan, M. V., Nair, N., Babalyan, V., Hutchings, N., et al. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0665 · Cited by 343
Carpagnano, G. E., Di Lecce, V., Quaranta, V. N., Zito, A., Buonamico, E., Capozza, E., Palumbo, A., Di Gioia, G., Valerio, V. N., & Resta, O. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01370-x · Cited by 307
Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection
Hernández, J. L., Nan, D., Fernandez-Ayala, M., García-Unzueta, M., Hernández-Hernández, M. A., López-Hoyos, M., Muñoz-Cacho, P., Olmos, J. M., Gutiérrez-Cuadra, M., Ruiz-Cubillán, J. J., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa733 · Cited by 279
Annweiler, G., Corvaisier, M., Gautier, J., Dubée, V., Legrand, E., Sacco, G., & Annweiler, C. (2020) · Nutrients · doi:10.3390/nu12113377 · Cited by 257
Vitamin-D and COVID-19: do deficient risk a poorer outcome?
Mitchell, F. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30183-2 · Cited by 250
Current sample size conventions: Flaws, harms, and alternatives
Bacchetti, P. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-17 · Cited by 232
Vitamin D for COVID-19: a case to answer?
Martineau, A. R., & Forouhi, N. G. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30268-0 · Cited by 189
Aglipay, M., Birken, C. S., Parkin, P. C., Loeb, M. B., Thorpe, K. E., Chen, Y., Laupacis, A., Mamdani, M., Macarthur, C., Hoch, J. S., et al. (2017) · JAMA · doi:10.1001/jama.2017.8708 · Cited by 165
Large, Single-Dose, Oral Vitamin D Supplementation in Adult Populations: A Systematic Review
Kearns, M. D., Alvarez, J. A., & Tangpricha, V. (2013) · Endocrine Practice · doi:10.4158/ep13265.ra · Cited by 146
Aibana, O., Huang, C., Aboud, S., Arnedo-Pena, A., Becerra, M. C., Bellido-Blasco, J. B., Bhosale, R. A., Calderon, R. I., Chiang, S. S., Contreras, C. C., et al. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002907 · Cited by 144
Franco, A. S., Freitas, T. Q., Bernardo, W. M., & Pereira, R. M. R. (2017) · Medicine · doi:10.1097/md.0000000000007024 · Cited by 112
Self-citationSimple, Defensible Sample Sizes Based on Cost Efficiency
Bacchetti, P., McCulloch, C. E., & Segal, M. R. (2008) · Biometrics · doi:10.1111/j.1541-0420.2008.01004_1.x · Cited by 111
Campbell, G. R., & Spector, S. A. (2012) · Autophagy · doi:10.4161/auto.21154 · Cited by 92
Vitamin D Receptor polymorphisms and risk of enveloped virus infection: A meta-analysis
Laplana, M., Royo, J. L., & Fibla, J. (2018) · Gene · doi:10.1016/j.gene.2018.08.017 · Cited by 92
Cited by
Drug treatments for covid-19: living systematic review and network meta-analysis
Siemieniuk, R. A., Bartoszko, J. J., Zeraatkar, D., Kum, E., Qasim, A., Díaz Martinez, J. P., Izcovich, A., Rochwerg, B., Lamontagne, F., Han, M. A., et al. (2020) · BMJ · doi:10.1136/bmj.m2980 · Cited by 846
The health effects of vitamin D supplementation: Evidence from human studies
Bouillon, R., Manousaki, D., Rosen, C., Trajanoska, K., Rivadeneira, F., & Richards, J. B. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00593-z · Cited by 535
Consensus statement on vitamin D status assessment and supplementation: Whys, whens, and hows
Giustina, A., Bilezikian, J. P., Adler, R. A., Banfi, G., Bikle, D. D., Binkley, N. C., Bollerslev, J., Bouillon, R., Brandi, M. L., Casanueva, F. F., et al. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae009 · Cited by 392
Vitamin D, infections and immunity
Ismailova, A., & White, J. H. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09679-5 · Cited by 347
Barnes, P. W., Robson, T. M., Neale, P. J., Williamson, C. E., Zepp, R. G., Madronich, S., Wilson, S. R., Andrady, A. L., Heikkilä, A. M., Bernhard, G. H., et al. (2022) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-022-00176-5 · Cited by 121
“A gold-standard double-blind placebo-controlled RCT of 200,000 IU of vitamin D 3 in 240 patients hospitalised with moderate to severe COVID-19 disease did not find effects on length of stay or in-hospital mortality [232].”
Metadata
- Authors
- Murai, I. H., Fernandes, A. L., Sales, L. P., Pinto, A. J., Goessler, K. F., Duran, C. S. C., Silva, C. B. R., Franco, A. S., Macedo, M. B., Dalmolin, H. H. H., Baggio, J., Balbi, G. G. M., Reis, B. Z., Antonangelo, L., Caparbo, V. F., Gualano, B., & Pereira, R. M. R.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2021-03-16
- Volume
- 325
- Issue
- 11
- Pages
- 1053
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W3131821293
- Cited by
- 528
- References
- 23
- FWCI
- 68.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.